⚠
Active regulatory warning
Review required: Check FDA MedWatch, EMA, WADA for current status.
Last checked: 2026-05-29
1 Identity
Prohormones
Various: 1-Andro, 4-Andro, DHEA-derived
Use with CautionEvidence: LimitedRestrictedProhormones are steroid precursors (androstenedione, 1-androstenediol, 4-androstenediol, DHEA, etc.) that convert to active anabolic steroids in the body [1]. Most prohormones were banned by the US Anabolic Steroid Control Act of 2004 (and updated 2014 Designer Anabolic Steroid Control Act). DHEA remains legal as a supplement. Prohormones carry ALL the risks of anabolic steroids: liver toxicity, lipid disturbance, testosterone suppression, gynecomastia, and cardiovascular damage. They are WADA-banned and illegal without prescription in most countries [1].
2 Risk self-assessment
HIGH RISK — see overview [1].
Select factors above to see your risk level
4 Lab interpreter
See overview
Your level:
Enter a value above
⚕ For healthcare professionals. Does not replace clinical judgment.
5 Quick facts
CategoryRestricted
Safety levelUse with Caution
EvidenceLimited
RDAControlled substances (most)
Upper limit (UL)N/A — banned
Scientific nameVarious: 1-Andro, 4-Andro, DHEA-derived
HIGH RISK — see overview[1]
6 Dosage by population
Adults Moderate
See product label
Elderly Moderate
See product label
Consider reduced renal/hepatic clearance. Start at lower end of range.
Athletes Limited
Standard dose
Obesity Limited
Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
Renal Limited
Consult specialist
Dose adjustment may be needed in renal impairment.
Vegan Moderate
Standard dose
HIGH RISK — see overview [1].
7 Form comparison
| Form | Bioavailability | Vegan | Cost/day |
|---|---|---|---|
| ['See overview', 'restricted', 'See overview [1].'] | Standard | Check label |
8 Clinical evidence
Strong evidence
See overview [1]. HIGH
Moderate evidence
See overview [1]. MODERATE
Insufficient evidence
See overview [1]. LOW
9 Safety
🚩 Red flags — when to stop and refer
● HIGH RISK — see overview [1]
Pregnancy
CONTRAINDICATED [1].
Pediatric
NOT recommended [1].
10 Toxicity and overdose
11 Drug interactions
12 Supplement interactions
13 Laboratory monitoring
14 Deficiency and prevalence
Risk factors
• HIGH RISK — see overview [1].
15 Frequently asked questions
Key safety ▼
Prohormones are steroid precursors BANNED by the 2004/2014 Anabolic Steroid Control Acts (except DHEA). They convert to active anabolic steroids with ALL steroid side effects: liver toxicity, lipid disturbance, HPG suppression, gynecomastia. Still available on gray market. WADA-banned. 'Legal steroid' marketing is fraudulent — they ARE steroids (by conversion). Patients using prohormones need the same monitoring as steroid users [1].
16 Regulatory status
See overview: [1].
17 References
[1]See overview for key references. REVIEW
18 Related articles
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
Auto-updated from GMJ Newsroom. Articles tagged "Prohormones" appear here.
19 Cite this page
Vancouver
Pkhakadze G. Prohormones — safety profile [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/ingredients/prohormones/
APA 7th
Pkhakadze, G. (2026). Prohormones — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/prohormones/
CC BY 4.0
🛡 SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
GP
Reviewed by Prof. G. Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, PHIG
Last reviewed: May 2026 · Next: November 2026
This entry is provided for educational and public health purposes under CC BY 4.0. Consult your healthcare provider before starting any supplement. For corrections: info@accreditation.ge.
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD